• Journal Article

A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese Type 2 diabetes population

Citation

Beale, S. J., Bagust, A., Richter, A., Thieda, P., & Perry, A. (2003). A cost-effectiveness evaluation of adding rosiglitazone versus sulphonylurea to metformin in a US obese Type 2 diabetes population. Diabetologia, 46, A444-A444.

Abstract